R&D in the Alzheimer’s Field

By Business Review Editor

Pharma Deals Review: Vol 2007 Issue 79 (Table of Contents)

Published: 7 Jan-2007

DOI: 10.3833/pdr.v2007.i79.400     ISSN: 1756-7874

Section: Research & Development

Fulltext:

Abstract

GlaxoSmithKline and EPIX Pharmaceuticals entered into a worldwide alliance to discover, develop and market novel medicines targeting four G-protein coupled receptors (GPCRs) for treating Alzheimer’s disease...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details